Elisa Rossini

Sede Di Brescia. Via Antonio Bianchi. 9-25124
Brescia, 25124, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Genome sequence of the Myxoma virus Borghi vaccine strain.

Genome sequence of the Myxoma virus Borghi vaccine strain.

Journal: Vaccine
Published: July 11, 2025

Plasma extracellular vesicles and phosphorylated tau 181 as early biomarkers of cognitive impairment in Alzheimer's dementia.

Plasma extracellular vesicles and phosphorylated tau 181 as early biomarkers of cognitive impairment in Alzheimer's dementia.

Journal: Alzheimer's research & therapy
Published: March 05, 2025

Identification and Characterisation of a Myxoma Virus Detected in the Italian Hare (Lepus corsicanus).

Identification and Characterisation of a Myxoma Virus Detected in the Italian Hare (Lepus corsicanus).

Journal: Viruses
Published: February 12, 2024

The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study.

The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study.

Journal: Cells
Published: December 13, 2023

Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma.

Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma.

Journal: European journal of cancer (Oxford, England : 1990)
Published: December 13, 2023

Retrospective Analysis of Patient-Reported Adverse Drug Reactions in an Italian Allergy Unit: ALLERG-RAF Study.

Retrospective Analysis of Patient-Reported Adverse Drug Reactions in an Italian Allergy Unit: ALLERG-RAF Study.

Journal: Pharmacology
Published: August 17, 2023

Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines.

Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines.

Journal: International journal of molecular sciences
Published: February 26, 2023

FSCN1 as a new druggable target in adrenocortical carcinoma.

FSCN1 as a new druggable target in adrenocortical carcinoma.

Journal: International journal of cancer
Published: November 21, 2022

Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models.

Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models.

Journal: Endocrine-related cancer
Published: November 20, 2022

Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art?

Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art?

Journal: Expert opinion on pharmacotherapy
Published: July 25, 2022

An update on adrenocortical cell lines of human origin.

An update on adrenocortical cell lines of human origin.

Journal: Endocrine
Published: May 05, 2022

Ribociclib Cytotoxicity Alone or Combined With Progesterone and/or Mitotane in in Vitro Adrenocortical Carcinoma Cells.

Ribociclib Cytotoxicity Alone or Combined With Progesterone and/or Mitotane in in Vitro Adrenocortical Carcinoma Cells.

Journal: Endocrinology
Published: October 01, 2021
Showing 1-12 of 23

Last Updated: 09/26/2026